CIK: 0001728001
申报总市值
US$86.9亿
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AEGR 2 08-15-19 | Aegerion Pharmaceuticals | 股票-其他 | 45.05% | — | — | |
| 2 | ✓ | Vivus INC | 股票-其他 | 27.19% | — | — | |
| 3 | PTCT 3 08-15-22 | Ptc Therapeutics INC | 股票-医疗保健 | 26.79% | — | +2.19% | |
| 4 | HQ8F | Apollo Endosurgery INC | 股票-其他 | 0.97% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | PTCT 3 08-15-22 | Ptc Therapeutics INC | +5.1% | +2.19% | 加仓 |
| 2 | ✓ | Vivus INC | +4.3% | — | 不变 |
| 3 | HQ8F | Apollo Endosurgery INC | +0.1% | — | 不变 |
| 4 | AEGR 2 08-15-19 | Aegerion Pharmaceuticals | -0.8% | — | 不变 |
| 5 | ✓ | Sucampo Pharmaceuticals INC | — | EXIT | 清仓 |